BlackRock Finance, Inc. - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 137 filers reported holding ITEOS THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 2.26 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Finance, Inc. ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$55,368,573
-1.3%
3,731,036
-9.3%
0.00%0.0%
Q1 2024$56,126,146
+20.3%
4,114,820
-3.4%
0.00%0.0%
Q4 2023$46,666,108
-15.6%
4,261,745
-15.6%
0.00%
-50.0%
Q3 2023$55,308,099
-10.7%
5,050,968
+7.9%
0.00%0.0%
Q2 2023$61,965,769
+2.0%
4,680,194
+4.9%
0.00%0.0%
Q1 2023$60,745,594
-30.6%
4,463,306
-0.4%
0.00%
-33.3%
Q4 2022$87,483,093
+6.4%
4,479,421
+3.8%
0.00%0.0%
Q3 2022$82,241,000
+7.3%
4,317,157
+16.0%
0.00%
+50.0%
Q2 2022$76,659,000
-28.5%
3,721,237
+11.7%
0.00%
-33.3%
Q1 2022$107,203,000
+42.7%
3,331,313
+106.5%
0.00%
+50.0%
Q4 2021$75,111,000
+78.5%
1,613,228
+3.5%
0.00%
+100.0%
Q3 2021$42,072,000
+8.1%
1,558,236
+2.7%
0.00%0.0%
Q2 2021$38,905,000
-25.8%
1,516,738
-1.1%
0.00%
-50.0%
Q1 2021$52,409,000
+45.5%
1,533,322
+44.0%
0.00%
+100.0%
Q4 2020$36,009,000
+120.3%
1,064,746
+60.7%
0.00%0.0%
Q3 2020$16,342,000662,4100.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$29,989,69616.06%
MPM BioImpact LLC 1,745,943$19,118,0765.10%
Saturn V Capital Management LP 994,756$10,892,5784.56%
Boxer Capital, LLC 1,804,058$19,754,4351.05%
RA Capital Management 4,417,259$48,368,9860.95%
683 Capital Management, LLC 810,000$8,869,5000.69%
Ikarian Capital, LLC 346,471$3,793,8570.46%
Ikarian Capital, LLC 3,056$3,346,3200.40%
BVF INC/IL 1,259,476$13,791,2620.37%
DAFNA Capital Management LLC 98,560$1,079,2320.34%
View complete list of ITEOS THERAPEUTICS INC shareholders